Thalidomide-NH-CH2-COOH
Thalidomide-NH-CH2-COOH is an innovative thalidomide derivative featuring a carboxylic acid functional group at the amino position, making it an optimal linker handle for PROTAC (Proteolysis Targeting Chimera) synthesis. As an E3 Ligase Ligand targeting cereblon (CRBN), this compound enables the development of targeted protein degraders by recruiting the CRBN E3 ubiquitin ligase complex. Ideal for use in academic research and drug discovery, Thalidomide-NH-CH2-COOH serves as a versatile building block for designing CRBN-based PROTACs and molecular glues with diverse target proteins and therapeutic applications.
Structure of 927670-97-1
Assurance
Delivery
Support
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
- Comprehensive PROTAC Platform
- Scientific Expertise & Technical Support
- Custom Synthesis & Design Service
- Extensive Product Coverage
- Cutting-Edge Innovation
- Fast Delivery & Global Support
- 24/7 customer service
- 100% quality assurance
Popular Publications Citing BOC Sciences Products
Background Introduction
Thalidomide-NH-CH2-COOH is a thalidomide derivative specifically engineered for use in targeted protein degradation research. As a potent immunomodulatory imide drug (IMiD) analog, it acts as an efficient Cereblon (CRBN) E3 ligase ligand and is an integral component in Proteolysis Targeting Chimera (PROTAC) technologies. With the introduction of an amino-methylene-carboxyl linker at the 4-position, Thalidomide-NH-CH2-COOH provides a reactive and flexible carboxyl functionality for seamless conjugation and PROTAC construction, supporting advanced degrader design in drug discovery.
Mechanism
Thalidomide-NH-CH2-COOH operates by binding to the Cereblon (CRBN) subunit of the CUL4-CRBN E3 ubiquitin ligase complex. By serving as a high-affinity E3 ligase ligand, it enables the recruitment of CRBN to PROTAC molecules. When conjugated to a ligand for a protein of interest via its carboxyl-functionalized linker, it brings the E3 ligase in close proximity to the target protein, facilitating ubiquitination and subsequent proteasomal degradation. The NH-CH2-COOH linker ensures efficient and site-specific conjugation, supporting optimized PROTAC design and target engagement.
Applications
Thalidomide-NH-CH2-COOH is highly valued in the synthesis and optimization of CRBN-based PROTACs and molecular glue degraders. Its reactive carboxylic acid linker is ideal for coupling with diverse target protein ligands, enabling rapid development of bifunctional molecules for research and drug development. Key applications include:
• Construction of CRBN E3 ligase-recruiting segments in PROTAC synthesis• Medicinal chemistry projects focused on target validation and SAR studies
• Accelerated development of molecular glues for selective protein degradation
• Custom synthesis and library generation for pharmaceutical R&D and academic research
• Consistent batch-to-batch reproducibility with complete QC documentation
• Supplied with COA, MSDS, and analytical data for traceability
• Reliable global shipping with stability-guaranteed packaging
• Dedicated technical support and optional custom synthesis service
• Demonstrates strong binding affinity to CRBN, VHL, or other E3 ligases
• Enables stable E3 ligase recruitment for targeted protein degradation
• Versatile amine-carboxyl functionalization enables easy conjugation to bioactive molecules.
• Highly effective for designing CRBN E3 ligase-recruiting PROTACs, facilitating targeted protein degradation applications.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Related Product Recommendations
Please contact us with any specific requirements and we will get back to you as soon as possible.





